MEDICA LABMED FORUM

10:30 – 12:30 h

Metagenomics and metabolomics

10:30 – 10:45 h
Introduction: Metagenomics and metabolomics
Prof. Dr. Beniam Ghebremedhin, Witten/Herdecke University, HELIOS University Hospital Wuppertal, Germany

10:45 – 11:05 h
Metagenomics in COVID-19 and co-infections
Prof. Dr. Dr. André Gessner, University Hospital Regensburg, Germany

11:05 – 11:20 h
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Ivayla Roberts, University of Liverpool, United Kingdom

11:20 – 11:35 h
Comprehensive meta-analysis of COVID-19 global metabolomics datasets
Prof. Dr. Jianguo Xia, McGill University Montreal, Canada

11:35 – 11:50 h
VOC technology for SARS-CoV-2 and Influenza virus detection
Dr. Wolfgang Vautz, ION-GAS GmbH, Germany

11:50 – 12:30 h
Roundtable discussion: Metagenomics and metabolomics

12:30 – 14:00 h

Lunch break

14:00 – 16:00 h

Immunity and vaccination

14:00 – 14:15 h
Introduction: Immunity and vaccination
Prof. Dr. Beniam Ghebremedhin, Witten/Herdecke University, HELIOS University Hospital Wuppertal, Germany

14:15 – 14:30 h
Multisystem inflammatory syndrome in children and SARS-CoV-2 serology
Prof. Dr. Steven L. Zeichner, University of Virginia, United States

14:30 – 14:45 h
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
Dr. Sebastian Ulbert, Fraunhofer Institute for Cell Therapy and Immunology, Germany

14:45 – 15:00 h
Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
Prof. Dr. Steven L. Zeichner, University of Virginia, United States

15:00 – 15:15 h
An assessment on impact of COVID-19 infection in a gender specific manner
Prof. Dr. Partha Roy, Indian Institute of Technology Roorkee, India

15:15 – 16:00 h
Roundtable discussion: Immunity and vaccination


[Version: 05 August 2021, subject to change]

10:30 – 12:30 h

Cardiac diagnostics in times of COVID-19

10:30 – 10:45 h
Introduction: Cardiac diagnostics in times of COVID-19
Prof. Dr. Stefan Holdenrieder, German Heart Center Munich, Germany

10:45 – 11:00 h
Stress markers: cfDNA in marathon runners and COVID-19 patients
Prof. Dr. Dr. Perikles Simon, University of Mainz, Germany

11:00 – 11:15 h
Training and fitness testing in long COVID patients
Prof. Dr. Billy Sperlich, University of Würzburg, Germany

11:15 – 11:30 h
Cutting edge biomarkers in cardiology
Prof. Dr. Wolfgang Koenig, German Heart Center Munich, Germany

11:30 – 11:45 h
Atherosclerotic cardiovascular disease – Lipid risk factors and beyond
Prof. Dr. Ralph Burkhardt, University Hospital Regensburg, Germany

11:45 – 12:30 h
Roundtable discussion: Cardiac diagnostics in times of COVID-19

12:30 – 13:00 h

Lunch break

 

13:00 – 13:20 h
Industry Slot
Martin Klaus Schmidt, Palas GmbH

13:20 – 14:00 h
COVID-19 from pandemic to endemic: how diagnostic labs should evolve to cope with the transition
Maria Avelia De Lorenzis, Sentinel Diagnostics

14:00 – 16:00 h

Liquid profiling and immune therapies in oncology

14:00 – 14:15 h
Introduction: Liquid profiling and immune therapies in oncology
Prof. Dr. Stefan Holdenrieder, German Heart Center Munich, Germany

14:15 – 14:30 h
New aspects of liquid profiling diagnostics in oncology
Prof. Dr. Ellen Heitzer, Medical University of Graz, Austria

14:30 – 14:45 h
Experience with implementing liquid profiling into standard care
Dr. med. Verena Haselmann, University Hospital Mannheim, Germany

14:45 – 15:00 h
Monitoring of conventional and immune therapies by molecular biomarkers
Prof. Dr. Michel van den Heuvel, Radboud University Medical Center, The Netherlands

15:00 – 15:15 h
Exosome-associated miRNA, mRNA and lncRNA diagnostics
Prof. Dr. Michael Pfaffl, Technical University of Munich, Germany

15:15 – 16:00 h
Roundtable discussion: Liquid profiling and immune therapies in oncology


[Version: 11 November 2021, subject to change]

10:30 – 12:30 h

Diversity at its best

10:30 – 10:45 h
Introduction: Diversity at its best
Dr. med. Verena Haselmann, University Hospital Mannheim, Germany

10:45 – 11:00 h
Accessing the repertoire of SARS-CoV-2 specific CD8+ T cell receptors
Karolin Wagner, Technical University of Munich, Germany

11:00 – 11:15 h
Bioactive lipids in extracellular vesicles
Dr. Mitja L. Heinemann, University of Leipzig Medical Center, Germany

11:15 – 11:30 h
Laboratory diagnostics in Bolivia – Challenges and perspectives
Rodrigo Pessoa Rejas, Instituto Bioclínico Cruceño, Bolivia

11:30 – 11:45 h
Multimodal liquid biopsy – The value of a single blood draw in breast cancer management
Dr. Corinna Keup, University Hospital Essen, Germany

11:45 – 12:30 h
Roundtable discussion: Diversity at its best

12:30 – 14:00 h

Lunch break

14:00 – 16:00 h

Integrative and AI-driven diagnostics

14:00 – 14:15 h
Introduction: Integrative and AI-driven diagnostics
Dr. med. Verena Haselmann, University Hospital Mannheim, Germany

14:15 – 14:30 h
CELLnet: automated white blood cell differential counting using AI
Tara Moghiseh, Winner of the Young Researchers Contest 'Jugend Forscht' 2019, Germany

14:30 – 14:45 h
The value of integrative diagnostics for management of colorectal cancer patients and the need for AI-driven solutions
Dr. Matthias Frölich, University Hospital Mannheim, Germany

14:45 – 15:00 h
The use of AI-driven algorithms to improve standard care
Niroshan Nadarajah, Munich Leukemia Laboratory (MLL), Germany

15:00 – 15:15 h
Smart Lab Diagnostics – Development of a software solution
Florian Stumpe, medicalvalues GmbH, Germany

15:15 – 16:00 h
Roundtable discussion: Integrative and AI-driven diagnostics


[Version: 15 October 2021, subject to change]

10:30 – 12:30 h

Next-generation biosensing

10:30 – 10:33 h
Welcome: Next-generation biosensing
Dr. Peter Quick, Association of the Diagnostics Industry (VDGH), Life Science Research Department (FA LSR), Germany

10:33 – 10:40 h
Introduction: Next-generation biosensing
Dr. Can Dincer, University of Freiburg, Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) & Department of Microsystems Engineering (IMTEK), Germany

10:40 – 11:05 h
Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification
Dr. Ole Behrmann, Fraunhofer Institute for Silicon Technology, Germany

11:05 – 11:30 h
A CRISPR discovery enables multiplexed RNA detection
Prof. Dr. Chase Beisel, Helmholtz Institute for RNA-based Infection Research, Germany

11:30 – 11:55 h
Disposable silicon-based electrochemical micro-qPCR
Dr. Firat Güder, Imperial College London, Department of Bioengineering, United Kingdom

11:55 – 12:20 h
Lab-on-PCB microsystem for multiple sepsis-related protein biomarker quantification
Dr. Despina Moschou, University of Bath, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) & Department of Electronic & Electrical Engineering, United Kingdom

12:20 – 12:30 h
Discussion: Next-generation biosensing

12:30 – 14:00 h

Lunch break

14:00 – 16:00 h

Immunity testing

14:00 – 14:05 h
Welcome: Immunity testing
Dr. Peter Quick, Association of the Diagnostics Industry (VDGH), Life Science Research Department (FA LSR), Germany

14:05 – 14:25 h
Affinity biosensors for COVID-19 antibodies
Prof. Dr. Paul Millner, University of Leeds, United Kingdom

14:25 – 14:45 h
COVID-19 testing in school using olfactory meter
Dr. Gerhard Kahr, Genius5-Instruments GmbH, Austria

14:45 – 15:05 h
High-throughput microfluidic nano-immunoassay for anti-SARS-CoV-2 antibodies
Dr. Grégoire Michielin, École Polytechnique Fédérale de Lausanne (EPFL), Switzerland

15:05 – 15:25 h
Digital rapid LFT with integrated quality control
Alexander Volk, ams AG, Austria

15:25 – 15:45 h
Emulating alveolus biology within a biochip: Microphysiological systems as translational tool in COVID-19 research
Dr. Martin Raasch, Dynamic42 GmbH, Germany

15:45 – 16:00 h
Discussion: Immunity testing


[Version: 12 August 2021, subject to change]